Tuesday, April 23, 2024
English English French Spanish Italian Korean Japanese Russian Hindi Chinese (Simplified)

Researchers at the Indian Institute of Technology (IIT) in Madras, Tel Aviv University, and Columbia University are working to develop a treatment for a rare genetic brain disease called GNB1 Encephalopathy. This neurological disorder affects fetuses and has fewer than 100 documented cases worldwide. Symptoms of GNB1 Encephalopathy include delayed physical and mental development, intellectual disabilities, and frequent epileptic seizures. Due to the high cost of genome sequencing, not many parents opt for it early on, making it difficult to diagnose and treat the disease in its early stages.


* indicates required

The Enterprise is an online business news portal that offers extensive reportage of corporate, economic, financial, market, and technology news from around the world. Visit to explore daily national, international & business news, track market movements, and read succinct coverage of significant events. The Enterprise is also your reach vehicle to connect with, and read about senior business executives.

Address: 150th Ct NE, Redmond, WA 98052-4166

©2024 The Enterprise – All Right Reserved.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept